Search results
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
Motley Fool via Yahoo Finance· 11 hours agoThe rheumatoid arthritis drug's sales declined by nearly 36% during the period, falling to less than...
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Zacks via Yahoo Finance· 4 days agoThe targeted CD markets are highly competitive. If approved, Lilly will face stiff competition from...
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 3 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165? | The Motley...
The Motley Fool· 6 days agoWall Street is feeling pretty good about AbbVie's (ABBV -1.19%) performance in 2024 so far. Chen...
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 6 days agoThe board will seek public comments, additional information and data over the next 60 days to...
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Motley Fool via Yahoo Finance· 2 days agoThe company began facing biosimilar competition for its top-selling drug, Humira, last year....
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 2 days agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
This Is What Whales Are Betting On AbbVie - AbbVie (NYSE:ABBV)
Benzinga· 4 days agoThe company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including ...
NBC's 'SNL' 50th Anniversary Season Signs 4 Presenting Sponsors
MediaPost· 6 days agoNBC has inked four season-long "presenting sponsors" for the 50th anniversary season of longtime weekend late-night show "Saturday Night Live."
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 2 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately 903,885 ...